WebApr 10, 2024 · Am 10. April 2024 gab eBay Inc. bekannt, dass es einen Aktionärsantrag von John Chevedden erhalten hat, in dem der Vorstand aufgefordert wird, die notwendigen Schritte zu unternehmen, um die entsprechenden Unternehmensdokumente zu ändern und den Eigentümern von insgesamt 10 % unserer ausstehenden Stammaktien das Recht zu … WebJan 23, 2024 · Jounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of Directors. CAMBRIDGE, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Jounce Therapeutics, …
Robert Iannone - Biography
WebMay 3, 2024 · CAMBRIDGE, Mass. and GOSSELIES, Belgium, May 03, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and ... WebMar 8, 2024 · Robert Iannone JAZZ stock SEC Form 4 insiders trading Robert has made over 1 trades of the Jazz Pharmaceuticals plc stock since 2024, according to the Form 4 filled … tremitsko otočje
final days to CAMBRIDGE HEALTHTECH INSTITUTE’S 13th …
WebSee the breakdown of the total annual compensation for Robert Iannone, M.D., M.S.C.E. for being a board member of Jounce Therapeutics, Inc., as well as other members of the … WebDr. Robert Iannone, M.S.C.E., brings more than 16 years of experience in clinical drug development. He currently serves as Executive Vice President, Research and Development & Chief Medical Officer at Jazz Pharmaceuticals, where he oversees product development, clinical operations and regulatory affairs. Before that, Dr. Iannone was the Head of ... WebRobert Iannone SVP & Head, Immuno-Oncology, AstraZeneca Roy D. Baynes SVP & Head, Global Clinical Development, Merck George Poste Chief Scientist, Complex Adaptive Systems Arizona State Univ. Nicholas C. Dracopoli VP, Oncology Diagnostics, Janssen R&D Lawrence J. Lesko Clinical Professor, Systems Pharmacology Univ. of Florida Stefan … tremisa zaragoza